GFAP and Parkinson disease: In agreement with previous studies, our study showed that the toxin MPTP induces phenotypes associated with Parkinson’s disease in mice such as decreased levels of dopamine and GSH; increased levels of MDA, iNOS, and TNF-α; and increased numbers of GFAP positive astrocytes.